Mankind Pharma is currently trading at RS. 2569.80, up by 2.05 points or 0.08% from its previous close of RS. 2567.75 on the BSE.

The stock opened at RS. 2567.75 and recorded an intraday high of RS. 2645.90 and a low of RS. 2560.00. A total of 26,808 shares have been traded so far.

Listed under BSE group 'A', the stock with a face value of RS. 1 touched a 52-week high of RS. 3050.00 on December 23, 2024, and a 52-week low of RS. 1910.10 on August 5, 2024. In the past week, the scrip has seen a high of RS. 2645.90 and a low of RS. 2506.55. The company's current market capitalization stands at RS. 105726.66 crore.

The shareholding pattern shows 72.68% stake held by promoters, 24.53% by institutional investors, and 2.79% by non-institutional investors.

Financially, Mankind Pharma reported an 18.37% decline in standalone net profit to RS. 412.76 crore for the quarter ended June 30, 2025, compared to RS. 505.66 crore in the same quarter last year. However, its total income rose by 3.86% to RS. 2605.58 crore from RS. 2508.66 crore during the same period.

On a consolidated basis, the net profit dropped by 18.30% to RS. 438.32 crore in Q1FY26 from RS. 536.49 crore in Q1FY25, while the total income jumped 23.02% to RS. 3650.23 crore as against RS. 2967.25 crore year-on-year.